Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model

Despite no or limited pre-clinical evidence, repurposed drugs are massively evaluated in clinical trials to palliate the lack of antiviral molecules against SARS-CoV-2. Here we use a Syrian hamster model to assess the antiviral efficacy of favipiravir, understand its mechanism of action and determin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nat Commun
Main Authors: Driouich, Jean-Sélim, Cochin, Maxime, Lingas, Guillaume, Moureau, Grégory, Touret, Franck, Petit, Paul-Rémi, Piorkowski, Géraldine, Barthélémy, Karine, Laprie, Caroline, Coutard, Bruno, Guedj, Jérémie, de Lamballerie, Xavier, Solas, Caroline, Nougairède, Antoine
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7979801/
https://ncbi.nlm.nih.gov/pubmed/33741945
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-021-21992-w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados